Uncategorized
Physicians, industry, investors convene for Ophthalmology Innovation Summit
CHICAGO – As has become the tradition, the Ophthalmology Innovation Summit was held on the Thursday prior to the American Academy of Ophthalmology with a goal to be a common ground to discuss the opportunities and obstacles to ophthalmic innovation. Ocular Surgery News has captured the substance and spirit of the remarks made by the speakers here during the BioPharma Company Showcase. Henry Hsu, MD, founder and CEO of Allysta Pharmaceuticals discussed the company’s development of Aly1337, a small molecule multikinase inhibitor for the treatment of glaucoma.